AI Longevity Improvements Expected to Boost Life Insurers — Market Talk

Life insurance providers should benefit from AI-fueled drug development improving overall life expectancy, Morgan Stanley analysts write in a note. "Given the current state of drug developments, scientific advances and other factors, we expect life expectancy in the US could improve faster than the…